Show simple item record

dc.contributor.authorGreen, JL
dc.contributor.authorWu, Y
dc.contributor.authorEncheva, V
dc.contributor.authorLasonder, Edwin
dc.contributor.authorPrommaban, A
dc.contributor.authorKunzelmann, S
dc.contributor.authorChristodoulou, E
dc.contributor.authorGrainger, M
dc.contributor.authorTruongvan, N
dc.contributor.authorBothe, S
dc.contributor.authorSharma, Vikram
dc.contributor.authorSong, W
dc.contributor.authorPinzuti, I
dc.contributor.authorUthaipibull, C
dc.contributor.authorSrichairatanakool, S
dc.contributor.authorBirault, V
dc.contributor.authorLangsley, G
dc.contributor.authorSchindelin, H
dc.contributor.authorStieglitz, B
dc.contributor.authorSnijders, AP
dc.contributor.authorHolder, AA
dc.date.accessioned2020-07-09T10:57:36Z
dc.date.issued2020-06-22
dc.identifier.issn1553-7366
dc.identifier.issn1553-7374
dc.identifier.othere1008640
dc.identifier.urihttp://hdl.handle.net/10026.1/15921
dc.description.abstract

Ubiquitylation is a common post translational modification of eukaryotic proteins and in the human malaria parasite, Plasmodium falciparum (Pf) overall ubiquitylation increases in the transition from intracellular schizont to extracellular merozoite stages in the asexual blood stage cycle. Here, we identify specific ubiquitylation sites of protein substrates in three intraerythrocytic parasite stages and extracellular merozoites; a total of 1464 sites in 546 proteins were identified (data available via ProteomeXchange with identifier PXD014998). 469 ubiquitylated proteins were identified in merozoites compared with only 160 in the preceding intracellular schizont stage, suggesting a large increase in protein ubiquitylation associated with merozoite maturation. Following merozoite invasion of erythrocytes, few ubiquitylated proteins were detected in the first intracellular ring stage but as parasites matured through trophozoite to schizont stages the apparent extent of ubiquitylation increased. We identified commonly used ubiquitylation motifs and groups of ubiquitylated proteins in specific areas of cellular function, for example merozoite pellicle proteins involved in erythrocyte invasion, exported proteins, and histones. To investigate the importance of ubiquitylation we screened ubiquitin pathway inhibitors in a parasite growth assay and identified the ubiquitin activating enzyme (UBA1 or E1) inhibitor MLN7243 (TAK-243) to be particularly effective. This small molecule was shown to be a potent inhibitor of recombinant PfUBA1, and a structural homology model of MLN7243 bound to the parasite enzyme highlights avenues for the development of P. falciparum specific inhibitors. We created a genetically modified parasite with a rapamycin-inducible functional deletion of uba1; addition of either MLN7243 or rapamycin to the recombinant parasite line resulted in the same phenotype, with parasite development blocked at the schizont stage. Nuclear division and formation of intracellular structures was interrupted. These results indicate that the intracellular target of MLN7243 is UBA1, and this activity is essential for the final differentiation of schizonts to merozoites.

dc.format.extente1008640-e1008640
dc.format.mediumElectronic-eCollection
dc.languageen
dc.language.isoen
dc.publisherPublic Library of Science (PLoS)
dc.subjectHumans
dc.subjectMerozoites
dc.subjectPlasmodium falciparum
dc.subjectProtozoan Proteins
dc.subjectUbiquitin
dc.subjectUbiquitination
dc.titleUbiquitin activation is essential for schizont maturation in Plasmodium falciparum blood-stage development
dc.typejournal-article
dc.typeJournal Article
dc.typeResearch Support, Non-U.S. Gov't
plymouth.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000544604600001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008
plymouth.issue6
plymouth.volume16
plymouth.publication-statusPublished online
plymouth.journalPLOS Pathogens
dc.identifier.doi10.1371/journal.ppat.1008640
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Health/School of Biomedical Sciences
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine/UoA01 Clinical Medicine
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CBR
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
dc.publisher.placeUnited States
dcterms.dateAccepted2020-05-17
dc.rights.embargodate2020-7-10
dc.identifier.eissn1553-7374
dc.rights.embargoperiodNot known
rioxxterms.versionofrecord10.1371/journal.ppat.1008640
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2020-06-22
rioxxterms.typeJournal Article/Review


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV